CAD 0.14
(-6.67%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 96.99 Million USD | -11.94% |
2022 | 110.13 Million USD | 168.19% |
2021 | 41.06 Million USD | -27.51% |
2020 | 56.65 Million USD | -18.18% |
2019 | 69.24 Million USD | 292.63% |
2018 | 17.63 Million USD | 158.78% |
2017 | 6.81 Million USD | 90.95% |
2016 | 3.56 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 93.96 Million USD | -1.2% |
2024 Q1 | 95.11 Million USD | -1.94% |
2023 Q4 | 96.99 Million USD | -3.13% |
2023 FY | 96.99 Million USD | -11.94% |
2023 Q1 | 101.07 Million USD | -8.23% |
2023 Q2 | 98.22 Million USD | -2.81% |
2023 Q3 | 100.12 Million USD | 1.94% |
2022 Q2 | 37.1 Million USD | -1.51% |
2022 Q4 | 110.13 Million USD | 247.92% |
2022 FY | 110.13 Million USD | 168.19% |
2022 Q1 | 37.67 Million USD | -8.27% |
2022 Q3 | 31.65 Million USD | -14.68% |
2021 Q1 | 53.3 Million USD | -5.91% |
2021 FY | 41.06 Million USD | -27.51% |
2021 Q4 | 41.06 Million USD | -8.55% |
2021 Q3 | 44.9 Million USD | -4.06% |
2021 Q2 | 46.8 Million USD | -12.19% |
2020 Q2 | 86.69 Million USD | 38.75% |
2020 Q1 | 62.48 Million USD | -9.76% |
2020 FY | 56.65 Million USD | -18.18% |
2020 Q4 | 56.65 Million USD | -11.48% |
2020 Q3 | 63.99 Million USD | -26.18% |
2019 Q3 | 51.88 Million USD | 132.51% |
2019 Q2 | 22.31 Million USD | 11.22% |
2019 Q1 | 20.06 Million USD | 13.76% |
2019 FY | 69.24 Million USD | 292.63% |
2019 Q4 | 69.24 Million USD | 33.46% |
2018 Q3 | 14.21 Million USD | 84.05% |
2018 Q1 | 8.27 Million USD | 21.41% |
2018 Q2 | 7.72 Million USD | -6.65% |
2018 Q4 | 17.63 Million USD | 24.06% |
2018 FY | 17.63 Million USD | 158.78% |
2017 Q4 | 6.81 Million USD | 0.0% |
2017 FY | 6.81 Million USD | 90.95% |
2016 FY | 3.56 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aurora Cannabis Inc. | 236.8 Million CAD | 59.042% |
Avicanna Inc. | 13.99 Million CAD | -592.835% |
Avant Brands Inc. | 33.22 Million CAD | -191.928% |
Cardiol Therapeutics Inc. | 8.45 Million CAD | -1047.267% |
Crescita Therapeutics Inc. | 5.77 Million CAD | -1579.19% |
Knight Therapeutics Inc. | 198.62 Million CAD | 51.169% |
MediPharm Labs Corp. | 10.93 Million CAD | -787.212% |
OrganiGram Holdings Inc. | 26.83 Million CAD | -261.471% |
Canopy Growth Corporation | 799.82 Million CAD | 87.874% |
Willow Biosciences Inc. | 3.23 Million CAD | -2896.293% |
Auxly Cannabis Group Inc. | 210.85 Million CAD | 54.002% |